Works by Haghighat, Shirin


Results: 13
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab reference product) in HER2-positive early-stage breast Cancer patients.

    Published in:
    BMC Pharmacology & Toxicology, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s40360-022-00599-x
    By:
    • Nodehi, Reza Safaei;
    • Kalantari, Behjat;
    • Raafat, Jahangir;
    • Ansarinejad, Nafiseh;
    • Moazed, Vahid;
    • Mortazavizadeh, Seyed Mohammad Reza;
    • Hosseinzadeh, Mehran;
    • Ghaderi, Bayazid;
    • Jenabian, Arash;
    • Qadyani, Mojtaba;
    • Haghighat, Shirin;
    • Allahyari, Abolghasem;
    • Mirzania, Mehrzad;
    • Seghatoleslami, Mohammad;
    • Payandeh, Mehrdad;
    • Alikhasi, Afsaneh;
    • Kafi, Hamidreza;
    • Shahi, Farhad
    Publication type:
    Article
    12
    13